Results 241 to 250 of about 2,258,994 (317)

METTL16 promotes MASLD progression through the regulation of lipid synthesis and immune response. [PDF]

Biol Direct
Li G, Wang L, Zhang L, Guo J, Sun Q.
europepmc   +1 more source

Understanding Further the Phenotypic Spectrum of Central Nervous System Inflammatory Demyelinating Disorders Using Unsupervised Clustering

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Central nervous system (CNS) inflammatory demyelinating syndromes, including multiple sclerosis (MS), aquaporin‐4 antibody–positive neuromyelitis optica spectrum disorder (AQP4 + NMOSD), and myelin oligodendrocyte glycoprotein (MOG) antibody–associated disease (MOGAD), occasionally overlap.
Bade Gulec, Elif Everest, Melih Tutuncu, Ugur Bilge, Sabahattin Saip, Ugur Uygunoglu, Aksel Siva   +6 more
wiley   +1 more source

Review of the Effects of Anesthetic Techniques and Medications on the Immune Response During the Perioperative Period. [PDF]

Med Sci Monit
Radkowski P, Pisula MJ, Malicki DK, Szewczyk M, Marczuk K, Mamala M, Grabarczyk Ł.   +6 more
europepmc   +1 more source

Ofatumumab in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease: A Comparison With Rituximab

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan, Lei Zhou, Jingzi ZhangBao, Hongmei Tan, Zhouzhou Wang, Chao Quan   +5 more
wiley   +1 more source

Cardiolipin's multifaceted role in immune response: a focus on interacting proteins. [PDF]

Front Immunol
Chai Z, Zhou Y, Hossain S, Huynh K, Hajimirzaei S, Zhang Y, Qi J, Zhang G, Li Z, Wei Y.   +9 more
europepmc   +1 more source

Injection site dictates the immune response to a biodegradable polymer and corresponding collagen regeneration. [PDF]

Bioact Mater
Zhang Y, Sun T, Li W, Fu Y, Yu Y, Shen R, Li J, Yu L, Ding J.   +8 more
europepmc   +1 more source

Enhancing immune response in advanced HCC with PVTT: rivaroxaban as a core adjuvant in combined therapy. [PDF]

J Immunother Cancer
Yan Y, Zou D, Li Y, Ma H, Chen H.
europepmc   +1 more source

The Steroidal Profile Modulates Adaptive Immune Response and Prognosis in Adrenocortical Carcinoma: Analysis of TCR and BCR Repertoires. [PDF]

Cancer Med
de Souza Resende JS, Giner IS, Muzzi JCD, Barbuto JAM, Lalli E, Castro MAA, de Figueiredo BC.   +6 more
europepmc   +1 more source

Transcriptional networks weaving natural killer anti-tumor immune response. [PDF]

Mol Cancer
Redavid AR, Bigliardi M, Ciarrocchi A, Reggiani F.   +3 more
europepmc   +1 more source

Immune response and vaccines

, 2015
K. Huygen
core